Marc Martinez-Llordella

Company: Quell Therapeutics

Job title: Co-founder & Vice President, Biology

Seminars:

Developing CAR-Treg Therapies to Enhance Clinical Efficacy 11:00 am

Discussing Treg engineering strategies to improve safety and efficacy Revealing insights into the ongoing LIBERATE clinical trial Exploring Treg stability and pharmacokinetics to enhance safetyRead more

day: Day 2 Treg Cell Therapy Track AM

Industry Leader’s Fireside Chat: Comparing Treg Cell Therapies & Treg Modulators as Effective Treatments for Inflammatory & Autoimmune Diseases 8:30 am

Exploring the effectiveness of treatment personalization to direct the future of Treg therapies Discussing technological challenges in Treg cell therapy, Treg modulator and antigen-specific therapy development Comparing Treg cell therapy and modulator treatment efficacy to identify enhancements to progress Treg therapiesRead more

day: Conference Day One AM